Background
An administrative law judge awarded Carl E. Lilly black lung benefits under the Black Lung Benefits Act, 30 U.S.C. §§ 901-944. The Benefits Review Board affirmed the award in proceeding No. 23-0306 BLA.
Greenbrier Minerals, LLC, insured through SummitPoint Insurance Company, petitioned the Fourth Circuit for review of the Board’s decision. The unpublished per curiam opinion does not describe the underlying medical or employment evidence or identify Greenbrier’s specific challenges to the award.
The Court’s Holding
The Fourth Circuit denied Greenbrier’s petition for review. The court concluded after reviewing the record that the Benefits Review Board’s decision was supported by substantial evidence and contained no reversible error, and it denied review for the reasons stated by the Board.
The court explained that its review was limited to whether substantial evidence supported the administrative law judge’s factual findings and whether the legal conclusions of the Board and the administrative law judge were rational and consistent with applicable law. It dispensed with oral argument because the written materials adequately presented the facts and legal issues and argument would not aid the decisional process.
Key Takeaways
- The Fourth Circuit left the administrative award of black lung benefits to Carl E. Lilly in place.
- Judicial review of a Benefits Review Board decision asks whether substantial evidence supports the administrative law judge’s findings and whether the agency’s legal conclusions are rational and consistent with applicable law.
- The unpublished opinion adopted the Board’s reasoning without separately discussing Greenbrier’s arguments or the evidentiary record.
Why It Matters
The decision illustrates the deferential review applied to black lung benefits determinations: the court does not reweigh the evidence but examines whether the administrative findings have adequate evidentiary support and whether the governing law was applied rationally.
Because the opinion is unpublished, it is not binding precedent in the Fourth Circuit. Its practical effect is to preserve Lilly’s benefits award while offering limited additional guidance beyond the established substantial-evidence standard.